-
Diagnostics World Brief | Roche announced that it has received the 510(k) clearance for its Elecsys Troponin T Gen 5 STAT blood test for patients with a suspected heart attack. Roche is now the first IVD company in the U.S. to provide the next generation Troponin testing for patients as an aid in the diagnosis of myocardial infarction.
Jan 20, 2017
-
Diagnostics World | Researchers have recently developed technology that is able to screen anticancer drugs inside tumors for their therapeutic potency. 100 nanometer liposomes were loaded with minuscule amounts of chemotherapeutics and synthetic DNA strands, or “barcodes,” that identify the therapeutics.
Jan 19, 2017
-
Forbes |
Google veteran Adrian Aoun has raised more than $30 million to create a new kind of tech-enabled medical practice that hopes to deliver better care at lower cost.
Jan 17, 2017
-
MIT Technology Review |
A strain of bacteria resistant to 26 different antibiotics killed a woman in Nevada, a stark warning that humanity continues to lose ground in the fight against antibiotic resistance.
Jan 13, 2017
-
Diagnostics World | Experts weigh in on the evolution of a whole new healthcare experience.
Jan 12, 2017
-
Diagnostics World News | In a new article on the American Association for Cancer Research’s blog, Charles Sawyers went into detail about the recent developments the AACR Project Genomics Evidence Neoplasia Information Exchange (GENIE) has launched, including releasing one of the largest fully public cancer genomic data sets to date.
Jan 11, 2017
-
Bio-IT World |
An epic CRISPR litigation battle between a host of universities has erupted involving CRISPR/Cas9, which can have major implications for the gene-editing technology community.
Jan 9, 2017
-
Diagnostics World News | Last week PatientsLikeMe announced a partnership and investment from iCarbonX that positions PatientsLikeMe as the cornerstone of Jun Wang's iCarbonX Digital Life Alliance, which aims to digitize and analyze all aspects of life.
Jan 9, 2017
-
Diagnostics World Brief | Two Pore Guys today announced the company is collaborating with oncologists at UCSF, to evaluate its handheld nanopore-based platform in the detection of cell-free, ctDNA from patient liquid biopsies.
Jan 6, 2017
-
Diagnostics World Brief | Foundation Medicine today announced that, as part of the succession of its executive leadership, the Board of Directors has appointed Troy Cox, a highly regarded global biopharma leader, as chief executive officer to succeed Michael Pellini.
Jan 6, 2017
-
Diagnostics World Brief | Human Longevity, Inc. today announced Cynthia Collins as the new Chief Executive Officer effective January 9, 2017. Collins, who has a successful track record and extensive leadership experience in the life sciences sector, will lead HLI and be responsible for all functions of the company including commercialization of HLI key products and strategic operations. She will also join the Board of Directors.
Jan 4, 2017
-
Diagnostics World News Brief | Illumina today announced it has named one of the world’s top clinical genomis experts to head its clinical genomics unit. Garret Hampton will join as Executive Vice President of Clinical Genomics for the company, starting January 9, 2017.
Jan 3, 2017
-
STAT |
The American Cancer Society estimates more than 76,000 Americans will have been diagnosed during 2016. The skin cancer rate has been rising for two decades.
Dec 28, 2016
-
Diagnostics World News Brief | Invitae announced the availability of 24 new and 19 expanded genetic test panels, allowing clinicians to gain information on 183 new genes with clinical and diagnostic significance.
Dec 22, 2016
-
Diagnostics World Briefs | News, products, and partnerships from around the diagnostics community including news from the Rare Genomics Institute, Good Start Genetics, HudsonAlpha, and more.
Dec 20, 2016
-
MobiHealthNews |
Scanadu, a personal health scanner company that shattered records on Indiegogo a few years ago, has raised $6.5 million according to an SEC filing.
Dec 19, 2016
-
Diagnostics World Brief | Roche is terminating its agreement with Pacific Bioscience. The biotech doesn’t intend to pursue efforts to develop a sequencing instrument for use in the clinical research and clinical market using PacBio’s Single Molecule, Real-Time (SMRT) technology. Roche retains no rights to the technology and PacBio is free to approach any market segments with their SMRT technology.
Dec 15, 2016
-
Diagnostics World Contributed Commentary | Today’s healthcare decisions are becoming more and more reliant on molecular diagnostic tests. It is incumbent upon diagnostic platform developers to design instruments and assays that give customers more value for their investment.
Dec 15, 2016